https://orcid.org/0000-0001-5454-1548
References
- Muncie HL Jr, Campbell J. α And β thalassemia. Am Fam Physician. 2009;80(4):339–344.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
- Lin M, Wang Q, Zheng L, et al. Prevalence and molecular characterization of abnormal hemoglobin in eastern Guangdong of Southern China. Clin Genet. 2012;81(2):165–171.
- Zheng CG, Liu M, Du J, et al. Molecular spectrum of α- and β-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, People’s Republic of China. Hemoglobin.2011;35(1):28–39.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Li J, Xie XM, Liao C, Li DZ. Co-inheritance of α-thalassaemia and β-thalassaemia in a prenatal screening population in mainland China. J Med Screen. 2014;21(4):167–171.
- He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031.
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
- Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020.
- Thein SL. Pathophysiology of β thalassemia – a guide to molecular therapies. Hematology Am Soc Hematol Educ Program. 2005:31–37.